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A B S T R A C T
Cardiac optical mapping utilises fluorescent dyes to directly image the electrical function of the heart at a high
spatio-temporal resolution which far exceeds electrode techniques. It has therefore become an invaluable tool in
cardiac electrophysiological research to map the propagation of heterogeneous electrical signals across the
myocardium. In this review, we introduce the principles behind cardiac optical mapping and discuss some of the
challenges and state of the art in the field. Key advancements discussed include newly developed fluorescent
indicators, tools for the analysis of complex datasets, panoramic imaging systems and technical and computa-
tional approaches to realise optical mapping in freely beating hearts.
1. Introduction
The transmission of electrical impulses in the heart is vital for the
coordinated contraction of the myocardium. Disturbances in how these
electrical signals, namely the cardiac action potential, are generated or
propagated can cause disruptions to maintenance of normal heart
rhythm or rate. These disturbances are typically known as cardiac ar-
rhythmias. Cardiac arrhythmias, and cardiovascular disease in general,
present a substantial health burden. Arrhythmias can lead to sudden
death, stroke or heart failure (Benjamin et al., 2019). Arrhythmogenic
triggers in complex conditions such as atrial fibrillation and heart
failure remain poorly understood. It is therefore vital to develop tools to
better understand healthy and abnormal cardiac electrical function to
inform more effective treatment for cardiac arrhythmias.
Since its introduction over 40 years ago, optical mapping has
transformed pre-clinical cardiac electrophysiology. Utilising fluorescent
indicators and high-speed cameras, electrical activation, repolarisation
and calcium handling can be imaged across myocardial preparations at
spatial resolutions far surpassing electrode techniques. Since the first
recording of optical action potentials (OAPs) in 1976 (Salama and
Morad, 1976), optical mapping has been applied to whole hearts, iso-
lated atria, wedge preparations, cardiac slices and cellular monolayers
(O'Shea et al., 2019c).
The unique characteristics of optical mapping has advanced our
understanding of electrical function and dysfunction in the heart. The
hypotheses of spiral waves in atrial fibrillation (Jalife, 2003), the
creation and consequence of ‘virtual electrodes’ in defibrillation
(Ripplinger et al., 2009), and cardiac transmural heterogeneity (Wen
et al., 2018) have all been elucidated using optical mapping technology.
These insights and the continued uptake of optical mapping in
cardiac research has been fuelled by significant technical advances in
camera technology, fluorescent dyes and experimental design. In this
review we provide a brief introduction to the basic principles and tools
underpinning optical mapping. We then focus on the current state-of-
the-art and challenges.
2. Basics of optical mapping
A basic optical mapping setup (Fig. 1a) can be split into 3 major
components: i) cardiac preparation loaded with fluorescent dye, ii) an
optical setup for dye excitation and collection of fluorescent output and
iii) a detector for imaging. By successful implementation of these
components, action potential (or calcium transient) propagation and
morphology can be directly imaged at high spatio-temporal resolution,
see Fig. 1b (O'Shea et al., 2019a).
In whole heart preparations, fluorescent dyes are commonly in-
troduced via Langendorff perfusion of the coronary arteries.
Superfusion of the atria, myocardial slices and wedges is also utilised by
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some investigators. Potentiometric dyes are the most widely used.
These dyes are designed to embed within the cell membrane and have a
fluorescent output that is responsive to the transmembrane voltage of
the cell, allowing the recording of optical actions potentials. The use of
these dyes however is not without limitations, see section 3. Optical
mapping also utilises intracellular calcium indicators which exhibit
increased fluorescent output on chelation of Ca2+ ions, allowing high
speed imaging of optical calcium transients, and simultaneous re-
cording of action potentials (O'Shea et al., 2019a).
Successful optical mapping relies on an appropriate optical and
imaging setup (Fig. 1a). Firstly, an illumination source is required,
ideally illuminating the entire sample homogenously. Due to low heat
emission, narrow spectral profile and long lifetime, LED illumination is
most used although Tungsten-Halogen lamps, Mercury/Xeon arc lamps
and lasers are also utilised. The illumination photons are then directed
on to the cardiac sample, where they excite the indicator and elicit
release of fluorescent photons. Optical filtering is required to separate
illumination and emission photons, and to effectively image the optical
signals. Pioneering optical mapping experiments utilised photodiode
arrays, however in current optical mapping setups CMOS and CCD
cameras dominate (O'Shea et al., 2019a).
3. State-of-the-art and challenges
3.1. Fluorescent dyes
As outlined, optical mapping relies on the use of fluorescent dyes.
Most commonly, these are potentiometric dyes, and in particular small
molecule synthetic indicators such as the electrochromism based styryl
dyes di-4-ANEPPS or rh-237. Although these molecules exhibit fast
responsive fluorescent changes (femto- to picosecond) in response to
transmembrane voltage, there are several important drawbacks to their
use. The fractional changes in fluorescence output are relatively small
(∼10 %), while photobleaching, phototoxicity and dye internalisation
can limit experimental time scales and lead to non-physiological al-
terations in the cardiac preparation (Matiukas et al., 2007; Larsen et al.,
2012).
Spectral characteristics of these dyes can also present challenges for
use in cardiac tissue. The di-4-ANEPPS for example requires excitation
by blue/green light. At these wavelengths, light is strongly absorbed by
biological chromophores in blood and tissue. Therefore, signals can
only be derived from near the preparation surface (preventing trans-
mural analysis). Although isolated studies using di-4-ANEPPS have
achieved optical mapping in blood perfused preparations (Zaitsev et al.,
2003), crystalloid solutions are commonly required to achieve sufficient
signal quality. Crystalloid solutions however are less able to meet the
metabolic and oxygen demands of cardiac tissue, a problem that is
compounded in freely beating preparations and can result in hypoxia
and ischemia (Garrott et al., 2017).
Consequently, efforts to develop better fluorescent dyes for optical
mapping experiments continue, including recent development of red-
shifted dyes. By shifting excitation ranges to red wavelengths (e.g. 650
nm as excitation wavelength for di-4-ANBDQPQ and di-4-ANBDQBS),
fractional changes in fluorescence can be achieved in blood perfused
myocardium that far exceed those of di-4-ANEPPS in the same pre-
parations (Matiukas et al., 2007). Penetration depth is increased due to
lack of absorption of excitation photons, and these dyes have also been
shown to be less resistant to signal decay by photobleaching and dye
internalisation. These properties have allowed optical mapping of in
vivo preparations (Lee et al., 2019), and transillumination approaches
for transmural integration (Mitrea et al., 2011).
Recently, photo-induced electron transfer has been exploited to
produce fast responsive dyes with higher fractional fluorescent changes,
such as FluoVolt. FluoVolt has been used for two-photon excitation
studies in mouse hearts, an alternative to transillumination as a method
for transmural integration (Salerno et al., 2019). Furthermore, signal
Fig. 1. Cardiac optical mapping setup, data
and analysis. A) Schematic representation of a
typical optical mapping setup for imaging a
potentiometric dye loaded cardiac preparation
(left). Inset shows the fluorescent indicator
embedded within the cellular membrane. The
potentiometric dye is excited by photons (green
arrows) from an illumination source. This
causes the release of fluorescent photons (red
arrows) whose spectral properties depend on
the transmembrane voltage. Fluorescent pho-
tons are filtered from the illumination photons
and directed to a high-density imaging detector
to produce a time series dataset. B) Example of
analyses possible from optical mapping data-
sets, including activation and signal mor-
phology mapping (left panel). Right panel
shows examples of the raw signals produced at
each pixel of an optical mapping dataset, in this
case optical action potentials from mouse ven-
tricles. Y axis denotes normalised fractional
fluorescence change (F/F0) from baseline
fluorescence level (F0). (For interpretation of
the references to colour in this figure legend,
the reader is referred to the web version of this
article).
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quality and phototoxic side effects can be alleviated using genetically
encoded sensors (e.g. Quasar voltage sensors, GCaMP calcium sensor),
which provide unique opportunity for combination with optogenetic
techniques and chronic investigation (O'Shea et al., 2019a). However,
genetic sensors exhibit slower response times when compared with
synthetic dyes (Broyles et al., 2018). For a wider discussion on voltage
and calcium indicators, the reader is directed to relevant reviews
(Broyles et al., 2018; O'Shea et al., 2019a).
3.2. Processing and analysis of optical mapping data
Optically recorded voltage signals often exhibit low and variable
signal to noise ratios (SNR), due to short exposure times and hetero-
geneous loading of the dyes which exhibit small fractional fluorescent
changes. Low SNR, coupled with large datasets constituting thousands
of image frames, means that substantial data processing is required
before data can be analysed, Fig. 2A. Complexity of processing and
analysis of this data has therefore previously acted as a barrier to up-
take of the optical mapping technology. However, recent developments
have seen the release and publication of open-source software dedi-
cated to the analysis of optical mapping data (Laughner et al., 2012;
O'Shea et al., 2019b), including panoramic analysis (Gloschat et al.,
2018).
3.3. Panoramic optical mapping
Optical mapping is predominantly performed with a single camera.
Thus, the curvature and surface topology of the 3D cardiac structures
imaged is visible only as a 2D projection. This may introduce artefacts
to the activation and repolarisation times measured. Furthermore,
viewing only one part of the heart is clearly inferior to multi-angle
panoramic imaging and can lead to researchers missing important
phenomena outside the field of view, Fig. 2B. Investigators have hence
introduced methods to undertake panoramic optical mapping with
projection of the optical data onto the 3D surface. Originally, mirrors
were utilised to achieve panoramic mapping in rabbit hearts (Bray
et al., 2000). Subsequently panoramic optical mapping was extended to
larger animal hearts using multi-camera solutions (Kay et al., 2004).
Recently, panoramic optical mapping has benefited from the open
source availability of both 3D printable hardware and analysis soft-
ware, (Gloschat et al., 2018). Nevertheless, whether panoramic optical
mapping completely overcomes the curvature problems remains to be
investigated.
3.4. Electromechanical mapping
Freely beating cardiac tissue has presented a significant challenge to
optical mapping. As tissue moves, the area being imaged by a specific
pixel will change, distorting the recorded time course of that pixel,
Fig. 2C. To overcome this challenge, excitation-contraction uncouplers
are employed. These molecules (e.g. Blebbistatin) prevent cardiomyo-
cyte contraction but not electrical excitation. They hence allow con-
tinuous recording of undistorted signals at each pixel location, but in
mechanically uncoupled hearts.
The uncoupled heart has a reduced energy and oxygen demand
(Garrott et al., 2017), lacks bidirectional interaction between electrical
and mechanical activity, and cannot be studied in vivo without ap-
proaches such as cardiopulmonary bypass (Lee et al., 2012). Some
studies suggest that the uncoupling agent Blebbistatin exerts additional
direct side effects on cardiac electrophysiology (Brack et al., 2013).
However, there are conflicting reports on the direct and indirect side
effects of Blebbistatin on cardiac electrophysiology (Fedorov et al.,
2007), and the reader is directed to (Kappadan et al., 2020) for a
thorough discussion on this subject.
For these reasons, technical and computational approaches have
been applied to realise optical mapping in freely beating preparations.
Excitation or emission ratiometry allows recording of two simultaneous
signals from the heart, both similarly corrupted by motion artefacts but
differentially responsive to voltage (or calcium concentration). This
enables mitigation of motion artefacts (Knisley et al., 2000; Bachtel
et al., 2011). Ratiometry alone however is often not sufficient to fully
remove motion artefacts owing to heterogeneous illumination and/or
Fig. 2. Challenges in cardiac optical map-
ping. A) Example of processing techniques that
are often applied on all pixels in an optical
mapping dataset to enhance the signal to noise
ratio of the raw data (left) to allow effective
parameter quantification (right). Note: The
exact methods and sequence of processing
methods used will vary depending on experi-
mental setup, model and analysis software
used. B) Schematic representation of a typical
imaged area (green) from a mouse whole heart
using a single camera setup. The red area
shows the area of the epicardial ventricular
surface that is not imaged. C) Example signals
from a mouse atrium where motion artefacts
are present. In the area with prolonged APD
(red), contraction has not been successfully
uncoupled, distorting the measured optical
signal. (For interpretation of the references to
colour in this figure legend, the reader is re-
ferred to the web version of this article).
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dye loading. Therefore, ratiometry has been combined with marker
tracking procedures to both remove motion artefacts, and map me-
chanical deformations simultaneously with optically recorded trans-
membrane voltage (Zhang et al., 2016; Garrott et al., 2017). Further-
more, methodologies such as optical flow have been utilised to track
motion without the requirement of fiducial markers (Kappadan et al.,
2020). These methods still operate under certain constraints, for ex-
ample homogenous illumination and sufficient regional contrasts, to be
successfully applied (Christoph and Luther, 2018). Whilst these ap-
proaches are currently not widely adopted, they demonstrate how the
reliance of optical mapping on un-physiological motion uncoupling can
be overcome.
3.5. In vivo optical mapping
Several of the challenges already discussed, (e.g. use of mechanical
uncouplers, dye toxicity, scattering and absorbance of optical signals by
biological chromophores) limit optical mapping to primarily ex vivo
applications. Achieving optical mapping in an in vivo setting, with a
freely beating blood perfused heart with intact circulation and nervous
system, would elevate the translatability of optical mapping and likely
lead to novel insights into arrhythmogenic drivers. Early attempts
showing the potential for in vivo optical mapping physically attached
optical fibres to the heart to suppress motion artefacts with limited
success (Dillon et al., 1998), while cardiopulmonary bypass has been
employed to permit the use of mechanical uncouplers in living anaes-
thetised animals (Lee et al., 2012).
More recently, developments such as excitation ratiometry of high
sensitivity red-shifted fluorescent dyes have been exploited to obtain
optical action potentials from beating porcine hearts in vivo in an open
chest model (Lee et al., 2019). Using an EMCCD camera, electrical
conduction could be mapped at high resolution during epicardial pa-
cing and ventricular fibrillation. Limitations remain nonetheless, with
persistent motion artefacts during pacing precluding effective mapping
of repolarisation dynamics during far-field imaging. However, by ima-
ging instead with an optical fibre array pressed against the epicardial
surface, activation and repolarisation could be effectively mapped, al-
though at a low resolution of 4 × 4 pixels (Lee et al., 2019). Further
advances, including the implementation of sophisticated motion
tracking techniques (Christoph and Luther, 2018; Kappadan et al.,
2020) and higher resolution optical fibre arrays will potentially fuel a
new era of in vivo optical mapping experiments.
3.6. Integrated cardiac optogenetics and optical mapping
While optical mapping focuses on the use of light to interrogate
cardiac electrophysiology, cardiac optogenetics allows light to be used
to activate, supress or modulate electrical behaviour. This is achieved
by the expression of opsins, light sensitive ion channels and pumps, in
cardiac preparations. Combination of optical mapping with optoge-
netics in sophisticated setups has seen the advent of all-optical elec-
trophysiology. These setups combine the high-resolution study of op-
tical mapping with precise, immediate actuation of cardiac tissue by
opsin activation (O'Shea et al., 2019a). Thus, all-optical electro-
physiology can be used for innovative experimentation, such as ‘real-
time simulations’ in cardiac cell monolayers (Burton et al., 2015) and
tissue (Scardigli et al., 2018).
4. Conclusion
Optical mapping has provided valuable insights into cardiac elec-
trophysiology in both health and disease. Using fluorescent indicators
rather than electrodes, it is possible to directly record cellular electrical
activity at spatial resolutions not possible with electrode techniques.
Optically recording the electrical activity of the heart also provides
unique challenges such as signal attenuation due to interaction of light
with cardiac tissue, motion artefacts, low and heterogenous signal
quality and 2D distortion of complex 3D geometries. Recent advances
however are overcoming these challenges, including development of
novel fluorescent dyes, panoramic imaging systems and technical and
computational approaches to allow recording from freely beating
hearts. Taken together, these advances are further enhancing the un-
ique role optical mapping plays in pre-clinical cardiac research, in-
cluding moving the technique towards direct in vivo optical mapping of
cardiac electrophysiology.
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